(Q41127918)

27 September 2017

1 reference

title

Treatment-resistant bipolar depression (English)

1 reference

27 September 2017

1 reference

Sachs GS

1

1 reference

27 September 2017

publication date

1 June 1996

1 reference

Psychiatric Clinics of North America

27 September 2017

published in

1 reference

27 September 2017

volume

19

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

215-236

1 reference

Clonazepam treatment of five lithium-refractory patients with bipolar disorder.

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Differential EEG Patterns in Affective Disorder and Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Antidepressant-induced mania and cycle acceleration: a controversy revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

The effect of lithium treatment on thyroid function in patients with primary affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Prophylactic lithium in affective disorders. Controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Thyroid abnormalities associated with rapid-cycling bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

A controlled evaluation of lithium prophylaxis in affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Clinical and psychological assessment of children of bipolar probands

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Prodromal symptoms in affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

The Use of Lithium in Affective Disorders: I. Acute Endogenous Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Relapse and impairment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Rapid cycling affective disorders in the mentally retarded.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Tranylcypromine versus imipramine in anergic bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Lithium prophylaxis of tricyclic-antidepressant-induced mania in bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Group psychotherapy with bipolar patients: a review and synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Differential Outcome of Pure Manic, Mixed/Cycling, and Pure Depressive Episodes in Patients With Bipolar Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Treatment of depression with clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Depression and hemispheric functions: changes associated with unilateral ECT

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Course of the Manic-Depressive Cycle and Changes Caused by Treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Five-year outcome for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Hypomania and marital conflict.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Family factors and the course of bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Therapeutic and Prophylactic Effects of Carbamazepine in Bipolar Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Lithium prophylaxis of bipolar illness. The value of combination treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Resistant bipolar affective disorder treated by stereotactic subcaudate tractotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Manic symptoms following addition of lithium to antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Lithium prophylaxis and expressed emotion

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Lithium prophylaxis in recurrent affective illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Alprazolam in bipolar-I depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Manic symptoms: an indication for bilateral ECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Bilateral and unilateral ECT: effects on verbal and nonverbal memory

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

The Use of Lithium in Affective Disorders, III: A Double-Blind Study of Prophylaxis in Bipolar Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Antidepressant-associated mania: a controlled comparison with spontaneous mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

A biopsychosocial approach to treating patients with affective disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Can antidepressants cause mania and worsen the course of affective illness?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Circadian rhythm mechanisms in affective illness and in antidepressant drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Phase Advance of the Circadian Sleep-Wake Cycle as an Antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

Controlled Studies of the Acute Antidepressant Effects of Lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970285-9

7 January 2021

10.1016/S0193-953X(05)70285-9

Identifiers

DOI

1 reference

27 September 2017

1 reference